Evoke Pharma
EVOK
EVOK
20 hedge funds and large institutions have $987K invested in Evoke Pharma in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
20
Holding in Top 10
–
Calls
–
Puts
$1K
Top Buyers
| 1 | +$33K | |
| 2 | +$10.3K | |
| 3 | +$6.32K | |
| 4 |
LNWTC
Laird Norton Wetherby Trust Company
Seattle,
Washington
|
+$5K |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.86K |
Top Sellers
| 1 | -$48K | |
| 2 | -$15K | |
| 3 | -$8.57K | |
| 4 |
Jane Street
New York
|
-$8K |
| 5 |
VF
Virtu Financial
New York
|
-$6.15K |